Getting Started with Certificates of Analysis: A Primer for New Research-Peptide Buyers
**Disclaimer:** This article is provided for educational and research purposes only. Peptides discussed herein are sold strictly as research chemicals and are not approved for human use. Nothing in this article constitutes medical advice. The information here is intended to help research professionals evaluate analytical documentation accompanying laboratory reagents.
Why a Certificate of Analysis Matters Before Anything Else
When a vial of lyophilized peptide arrives in your laboratory, the powder inside is, from your perspective as a researcher, an unknown. You did not synthesize it. You did not weigh it on your own balance. You did not run mass spectrometry on it yourself. The only objective evidence you have that the contents match the label is a Certificate of Analysis (COA) --- a document produced by the supplier, ideally with third-party verification, that summarizes the analytical data demonstrating identity and purity.
Every reproducible experiment that uses a peptide reagent depends on the integrity of that COA. If the COA is missing, vague, or shows results below acceptable thresholds, your downstream data inherits the uncertainty. This primer walks new buyers through the structure of a COA, what each section means, and what passing values look like for typical research-grade peptides.
For a deeper field-by-field walkthrough once you have grasped the fundamentals, see How to Read a Peptide COA and Reading HPLC COAs.
The Anatomy of a Standard COA
A complete COA for a research peptide typically contains the following blocks:
- Header information --- supplier name, batch (lot) number, manufacture date, retest or expiry date.
- Product identification --- peptide name, sequence (one-letter or three-letter amino acid code), molecular formula, theoretical molecular weight, CAS number where applicable.
- Appearance and physical properties --- colour, form (lyophilized powder, fluffy solid, etc.), solubility notes.
- [HPLC](/research/glossary#hplc) purity result --- the percentage of the main peak in the chromatogram relative to total integrated area.
- Mass spectrometry confirmation --- observed monoisotopic or average mass compared with theoretical mass.
- Counter-ion / salt content --- typically TFA (trifluoroacetate) or acetate, often expressed as net peptide content.
- Water content --- usually determined by Karl Fischer titration.
- Bioburden / endotoxin --- only on premium grades; not standard on most research lots.
- Signature and date of the analyst or QC officer.
If a COA is missing the HPLC chromatogram or the mass spectrum image, treat the reported numbers with caution. A summary table is not the same as the underlying data.
Reading the HPLC Chromatogram
High-performance liquid chromatography is the standard analytical technique for assessing peptide purity. The chromatogram is a two-dimensional plot: the x-axis represents time (typically 0 to 30 minutes) and the y-axis represents detector response (usually UV absorbance at 214 nm or 220 nm, where the peptide bond absorbs).
A clean, research-grade peptide chromatogram shows one dominant peak --- the main peak --- that accounts for the overwhelming majority of integrated area. Smaller peaks elsewhere in the run represent impurities: truncation products from incomplete coupling during synthesis, deletion sequences, oxidation products, or solvent peaks near the front of the run.
What passing values look like:
| Grade | HPLC Purity | Typical Use |
|---|---|---|
| Crude | 60--80% | Initial screening only |
| Standard research | greater than or equal to 95% | Most in-vitro and animal-protocol research |
| High purity | greater than or equal to 98% | Quantitative assays, structural biology |
| Premium / GMP-like | greater than or equal to 99% | Regulated research, clinical-adjacent work |
Most reputable research peptide suppliers list purity at or above 98%. A reported purity below 95% should prompt scepticism unless the application explicitly tolerates impurity (for example, an early-stage screening cascade where active fractions will be repurified).
The integration table beneath the chromatogram should list each peak's retention time and percent area. The main peak's retention time is also a soft check on identity --- the same peptide on the same column under the same gradient should elute at the same time across batches.
Reading the Mass Spectrum
HPLC tells you how clean your sample is. Mass spectrometry tells you whether the dominant species is the molecule you actually ordered. A 99% pure batch of the wrong peptide is still useless.
The mass spectrum plots mass-to-charge ratio (m/z) on the x-axis against signal intensity on the y-axis. For peptides, electrospray ionization (ESI-MS) typically produces a series of multiply charged ions ([M+H]+, [M+2H]2+, [M+3H]3+, and so on). MALDI-TOF instead produces predominantly singly charged [M+H]+ ions and is common for shorter peptides.
The pass criterion: the observed mass should match the theoretical mass within a small tolerance. For research peptides analyzed by ESI or MALDI, an observed-versus-theoretical agreement of within 1 mass unit is typically considered confirmatory. High-resolution instruments can resolve to fractions of a Dalton.
The COA should explicitly list both the theoretical mass (calculated from the sequence) and the observed mass (from the instrument). If only one is shown, that is a documentation weakness.
Counter-Ion and Net Peptide Content
Synthetic peptides made by Fmoc solid-phase synthesis typically come as TFA (trifluoroacetate) salts, because TFA is used in the cleavage and HPLC purification steps. Some peptides are subsequently exchanged into acetate or hydrochloride salts, particularly when TFA would interfere with downstream applications.
The net peptide content is the percentage of the total powder mass that is actually the peptide molecule, with the remainder being counter-ion and bound water. A 5 mg vial labelled "5 mg" typically refers to gross weight; net peptide may be 75--85% of that. For most exploratory research this is acceptable, but for any quantitative concentration calculation you must use the net peptide content from the COA, not the gross label weight. See our reconstitution guide for how this affects molarity calculations.
Batch (Lot) Traceability
Every analytical claim on a COA is tied to a specific manufactured lot. The lot number on the COA must match the lot number printed on the vial. If they do not match, the COA is not valid for that vial --- you have a paperwork problem at minimum and a reagent identity problem at worst.
Reputable suppliers archive COAs by lot indefinitely and can re-issue copies on request. Maintaining a lab notebook record that pairs each experiment with the lot number of the peptide used is good practice; it is the only way to retroactively investigate if a result later seems anomalous.
Red Flags on a COA
Treat the following as warning signs:
- No HPLC chromatogram image, only a numerical purity claim.
- Mass spectrum image absent or illegible.
- Theoretical mass not stated.
- Lot number missing or generic ("Lot: 001").
- No analyst signature, no date.
- Purity reported as a round number ("greater than 99%") with no actual percentage and no integration table.
- Different fonts or alignment irregularities suggesting the document has been edited.
- Identical chromatograms across multiple lots (suggests a template with no real per-lot testing).
Suppliers with nothing to hide produce COAs that look like analytical reports, not marketing documents.
Third-Party Versus In-House Testing
A COA generated entirely by the supplier's internal QC lab is informative but not independent. A third-party COA is generated by an external laboratory --- ideally ISO 17025 accredited --- and represents independent verification. Janoshik Analytical and similar specialist labs are widely used for peptide third-party testing in the research market.
When evaluating a new supplier, ask whether they provide third-party COAs, on which lots, and at what frequency. A supplier that provides third-party verification for every lot is operating at a higher quality tier than one that tests in-house only or third-party-tests occasionally.
Putting It Together: A Checklist for Each Incoming Vial
Before you log a peptide into your inventory, walk through this short checklist:
- Does the lot number on the vial match the COA?
- Is the HPLC purity at or above your required threshold (typically greater than or equal to 98% for most research)?
- Does the observed mass match the theoretical mass?
- Is the chromatogram dominated by a single peak with a clean baseline?
- Is there a counter-ion / net peptide content figure?
- Is the COA signed and dated?
- If the supplier offers third-party testing, is the third-party report attached?
If any item fails, contact the supplier before opening or reconstituting the vial. Once the vial is opened the chain of custody is yours.
Where to Go Next
A COA tells you what you have. Two further steps stand between the certificate and a usable solution: understanding the purity standards in depth (Understanding Peptide Purity) and selecting a supplier whose documentation meets your standard (Research Peptide Buying Guide).
Treat the COA as the foundation of your reagent quality system. Without it, every downstream measurement floats on assumptions.